Company Filing History:
Years Active: 2009
Title: Kazutoshi Kuroda: A Pioneer in Microcrystal Innovation
Introduction: Kazutoshi Kuroda is a notable inventor based in Ichikawa, Japan, recognized for his innovative contributions to the field of pharmaceutical formulations. With a strong focus on microcrystal technology, Kuroda's work has the potential to enhance drug solubility and bioavailability, leading to improved therapeutic outcomes.
Latest Patents: Kuroda holds one significant patent that focuses on microcrystals of (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione. This patent describes microcrystals that have an average particle size of less than 50 micrometers and exhibit a crystallinity of 20% or more. The invention emphasizes the compound's excellent solubility, stability, and dispersing properties in pharmaceutical formulations, thus paving the way for enhanced drug delivery systems.
Career Highlights: As a member of Kyowa Hakko Kirin Co., Limited, Kuroda has significantly impacted the pharmaceutical industry through his innovative work. His expertise in microcrystal technologies showcases his commitment to advancing pharmaceutical science and improving patient care.
Collaborations: Throughout his career, Kuroda has collaborated with esteemed colleagues, including Noboru Aoki and Toshiro Ochiai. These collaborations have allowed for the exchange of ideas and expertise, further driving innovation in the realm of drug formulation and development.
Conclusion: Kazutoshi Kuroda's contributions to the field of microcrystal technology represent a significant advancement in pharmaceutical formulations. His patent highlights the importance of innovation in improving drug solubility and bioavailability, with the potential to transform therapeutic applications in medicine.